OSE Immunotherapeutics SA (ORPOF) Revenue
OSE Immunotherapeutics SA Revenue
OSE Immunotherapeutics SA had a revenue of 1.30M in the quarter ending Dec 31, 2025, with -2.04%. This bring the company's revenue in the last twelve months to 2.62M, Increased 21.59%. In the fiscal year ending Dec 31, 2025, OSE Immunotherapeutics SA had annual revenue of 2.62M with -96.25% growth.
- Revenue (ttm)
- 2.62M
- Revenue Growth
- -96.09%
- P/S Ratio
- 19.65
- Revenue/Employee
- $40,922
- Employees
- 64
- Market Cap
- $51.46M
Revenue Chart
OSE Immunotherapeutics SA Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.62M | -67.26M | -96.25% |
| Dec 31, 2024 | 69.88M | 67.65M | 3037.72% |
| Dec 31, 2023 | 2.23M | -16.07M | -87.83% |
| Dec 31, 2022 | 18.30M | -8.00M | -30.43% |
| Dec 31, 2021 | 26.31M | 15.89M | 152.51% |
| Dec 31, 2020 | 10.42M | -15.53M | -59.86% |
| Dec 31, 2019 | 25.95M | 1.50M | 6.12% |
| Dec 31, 2018 | 24.46M | 17.77M | 266.00% |
| Dec 31, 2017 | 6.68M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| ORPOF | 2.62M |